Sickle Cell Mutation Screening Prenatal Test is a crucial examination offered by DNA Labs UAE, designed to detect the presence of sickle cell mutations in unborn babies. This test, priced at 1200 AED, involves analyzing the fetal DNA for specific genetic markers associated with Sickle Cell Anemia (SCA), a severe hereditary blood disorder. SCA affects the shape and functionality of red blood cells, leading to various health complications. Early detection through prenatal screening enables parents and healthcare providers to prepare and implement appropriate management strategies for affected children. Conducted in a state-of-the-art laboratory setting, this test represents a proactive approach to managing genetic health risks and ensuring the well-being of future generations.
The TELAML1 Quantitative Test is a specialized diagnostic procedure designed to detect and measure the presence of the TEL-AML1 fusion gene, which is often associated with certain types of leukemia, particularly Acute Lymphoblastic Leukemia (ALL). This genetic abnormality results from the translocation between chromosomes 12 and 21, and its identification is crucial for the accurate diagnosis, prognosis, and treatment planning for patients affected by this condition.
Performed at DNA Labs UAE, a leading facility in genetic testing, the TELAML1 Quantitative Test employs advanced molecular techniques to ensure precise and reliable results. The test is particularly valuable for monitoring disease progression or response to therapy in patients diagnosed with leukemia.
The cost of the TELAML1 Quantitative Test at DNA Labs UAE is 1200 AED. This investment is essential for those needing detailed genetic insights into their leukemia diagnosis, allowing for tailored treatment approaches and better management of the disease.
The Thiopurine Methyltransferase (TPMT) *2, *3A, *3B, *3C Genotyping Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to analyze specific genetic variants of the TPMT enzyme. These variants, known as *2, *3A, *3B, and *3C, significantly influence the body's ability to metabolize thiopurine drugs, which are commonly prescribed for conditions such as leukemia, autoimmune diseases, and inflammatory bowel disease.
The TPMT enzyme plays a crucial role in determining the optimal dosage of thiopurine medications for individual patients. Variations in the TPMT gene can lead to differences in enzyme activity, affecting drug efficacy and the risk of adverse reactions. Individuals with reduced or absent TPMT activity are at a higher risk of experiencing toxic side effects when taking standard doses of thiopurine drugs.
The genotyping test offered by DNA Labs UAE provides a precise and reliable method for detecting the presence of these critical TPMT variants. By identifying patients' TPMT genotype, healthcare providers can tailor thiopurine drug dosages to optimize therapeutic outcomes and minimize the risk of toxicity. This personalized approach to medication management enhances patient safety and treatment effectiveness.
The cost of the TPMT *2, *3A, *3B, *3C Genotyping Test at DNA Labs UAE is 1200 AED. This investment in precision medicine enables patients and their healthcare teams to make informed decisions regarding thiopurine therapy, ultimately leading to better health outcomes and improved quality of life for those affected by conditions requiring thiopurine treatment.
The TORCH Panel Real-Time PCR Test is a highly sensitive and specific diagnostic tool used to detect infections that could potentially harm an unborn baby or a newborn. This panel screens for a group of infections known as TORCH - Toxoplasmosis, Other agents (such as Syphilis, Varicella-Zoster Virus, and Parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes Simplex Virus (HSV). These infections can lead to severe fetal anomalies or birth defects if transmitted from mother to child during pregnancy.
Performed at DNA Labs UAE, the TORCH Panel Real-Time PCR Test employs polymerase chain reaction (PCR) technology to amplify and detect the DNA or RNA of the pathogens causing these infections. This makes the test highly accurate in identifying active infections, allowing for timely intervention and management to safeguard maternal and fetal health.
The cost of the TORCH Panel Real-Time PCR Test at DNA Labs UAE is 1200 AED. Considering the critical information it provides, the test represents a valuable investment in prenatal care, helping to ensure the health and well-being of both mother and child.
The Levetiracetam Test is a specialized diagnostic procedure designed to measure the levels of levetiracetam in the blood. Levetiracetam is a medication commonly used to treat epilepsy and other seizure disorders. By monitoring the concentration of this drug, healthcare providers can ensure that patients are receiving an optimal dose for seizure control while minimizing potential side effects. This test is particularly important for individuals who are starting levetiracetam therapy, experiencing uncontrolled seizures, or exhibiting signs of toxicity.
At DNA Labs UAE, the Levetiracetam Test is offered at a cost of 1470 AED. The facility is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable results. Patients or their caregivers can arrange for testing by contacting DNA Labs UAE directly. The test process is straightforward, typically requiring only a simple blood draw. Results from the Levetiracetam Test can help guide adjustments in medication dosage, contributing to more effective and safer epilepsy management.
The Ganglioside GD1a Antibody IgM Test is a specialized diagnostic procedure designed to detect the presence of IgM antibodies against ganglioside GD1a in the blood. Gangliosides are complex glycosphingolipids found in the cell membranes, particularly within the nervous system. The presence of antibodies against GD1a can be indicative of autoimmune neuropathies, such as Guillain-Barré Syndrome (GBS) or Multifocal Motor Neuropathy (MMN), conditions where the body's immune system mistakenly attacks part of the peripheral nervous system.
This test is crucial for the early detection and management of these conditions, providing valuable information that can guide treatment decisions. Conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic services, the Ganglioside GD1a Antibody IgM Test is available for a cost of 1470 AED. This test is a key tool in the neurological diagnostic process, offering insights into the underlying causes of neuropathic disorders and helping healthcare professionals develop targeted treatment plans for affected individuals.
The Anti NMDA Receptor Anti-Glutamate Antibody CSF Test is a specialized diagnostic procedure aimed at detecting antibodies against the NMDA (N-methyl-D-aspartate) receptor in the cerebrospinal fluid (CSF). These antibodies are indicative of autoimmune encephalitis, a serious condition where the body's immune system mistakenly attacks healthy brain cells, leading to inflammation and a range of neurological symptoms. This test plays a crucial role in diagnosing the condition, guiding treatment plans, and monitoring disease progression or response to therapy.
Performed at DNA Labs UAE, the test requires a sample of cerebrospinal fluid, which is collected through a lumbar puncture procedure. The laboratory employs advanced immunological techniques to identify the presence of anti-glutamate receptor antibodies, which are hallmark indicators of anti-NMDA receptor encephalitis.
The cost of the Anti NMDA Receptor Anti-Glutamate Antibody CSF Test at DNA Labs UAE is 1470 AED. Given the complexity of the test and the specialized expertise required to interpret the results, it represents a critical investment in accurately diagnosing and managing conditions associated with anti-NMDA receptor antibodies. Patients undergoing this test at DNA Labs UAE can expect state-of-the-art diagnostic facilities and professional care, ensuring reliable and timely results.
The Anti NMDA Receptor Anti-Glutamate Antibody Serum Test is a specialized diagnostic assessment designed to detect the presence of antibodies against the NMDA (N-methyl-D-aspartate) receptor in the serum. These antibodies are indicative of an autoimmune response that can affect the functioning of the central nervous system, leading to a range of neurological symptoms. Conditions such as Anti-NMDA Receptor Encephalitis, a rare but treatable form of encephalitis that often manifests with psychiatric symptoms, seizures, and movement disorders, are associated with these antibodies. The test plays a crucial role in the diagnosis and subsequent management of disorders related to NMDA receptor antibodies.
In the United Arab Emirates, this test is available at DNA Labs UAE, a reputable facility known for its comprehensive range of diagnostic services. The cost of the Anti NMDA Receptor Anti-Glutamate Antibody Serum Test at DNA Labs UAE is 1460 AED. Given the complexity and the specialized nature of this test, it's a critical tool for healthcare providers in the accurate diagnosis and treatment planning for patients presenting with symptoms suggestive of autoimmune encephalitis or other related neurological conditions.
The Glucagon Test is a diagnostic procedure used to evaluate the function of the pancreas, specifically how well it can produce glucagon. Glucagon is a hormone that plays a critical role in regulating blood glucose levels by stimulating the liver to convert stored glycogen into glucose, which is then released into the bloodstream. This test is particularly useful in diagnosing conditions related to abnormal blood sugar levels, such as diabetes and hypoglycemia, as well as assessing pancreatic tumors that produce glucagon.
To perform the test, a healthcare professional will administer an injection of glucagon to stimulate the liver's glucose production. Blood samples are then taken at various intervals to measure the glucose levels and assess the body's response to glucagon. The results can provide valuable insights into the patient's metabolic health and pancreatic function.
At DNA Labs UAE, the Glucagon Test is offered for a cost of 1460 AED. The facility is equipped with state-of-the-art technology to ensure accurate and reliable results. Patients choosing DNA Labs UAE can expect professional service and comprehensive support throughout the testing process, from preparation to understanding their test results.
The C1q binding test is a specialized laboratory assay designed to detect immune complexes in the blood, which are often indicative of autoimmune diseases or infections. This test operates on the principle of identifying the binding of the C1q molecule, a component of the complement system, to immune complexes. The complement system plays a crucial role in the immune response, aiding in the clearance of pathogens and immune complexes from circulation.
In the context of autoimmune diseases or certain infections, the body may form abnormal immune complexes, which can deposit in tissues and lead to inflammation and damage. The C1q binding test helps in diagnosing such conditions by providing evidence of the presence of circulating immune complexes.
At DNA Labs UAE, the test is conducted with precision and accuracy, ensuring reliable results for patients and healthcare providers. The cost of the C1q binding test at DNA Labs UAE is 1460 AED. This investment aids in the early detection and management of diseases associated with immune complexes, potentially guiding treatment options and monitoring disease progression.
